Angiocrine Bioscience is a private, clinical stage engineered cell therapy company harnessing the power of genetically modified human endothelial cells to regenerate tissues, restore function and rejuvenate patients with serious medical conditions.
Our team is developing a pipeline of proprietary engineered endothelial cell (E-CEL® ) therapies for treating multiple life-threatening hemato-oncologic and immunologic conditions, as well as, regenerating tissues and organs that have been injured or damaged by diseases.
Company Details
- Employees
- 17
- Founded
- -
- Address
- 11575 Sorrento Valley Rd,
- Phone
- 530-745-9560
- in****@****bio.com
- Industry
- Biotechnology
- Website
- angiocrinebioscience.com
- Keywords
- Proprietary genetically engineered cellular E-CEL™ Technology Platform, with potential applications in cellular immunotherapy for hematologic cancers, cellular regenerative medicine, hematopoietic stem cell gene therapy..
- HQ
- San Diego, California
Angiocrine Bioscience, Inc. Questions
Angiocrine Bioscience, Inc.'s helpline number is 530-745-9560
Angiocrine Bioscience, Inc.'s website is angiocrinebioscience.com
Angiocrine Bioscience, Inc.'s LinkedIn profile is https://www.linkedin.com/company/angiocrine-bioscience-inc-
Angiocrine Bioscience, Inc. has
17 employees.
View email and phone details for 17
employees at Angiocrine Bioscience, Inc..
Angiocrine Bioscience, Inc.'s industry is
Biotechnology
Angiocrine Bioscience, Inc.'s top competitors are
Atyr Pharma,
Talphera, Inc.,
Sorrento Therapeutics, Inc.,
Alterome Therapeutics, Inc,
Perceptive Advisors,
Apollo Therapeutics,
Neurocrine Biosciences,
Artiva Biotherapeutics,
Trilink Biotechnologies, Part Of Maravai Lifesciences,
Tracon Pharmaceuticals.
Angiocrine Bioscience, Inc.'s support email address is info@angiocrinebio.com
Angiocrine Bioscience, Inc.'s categories are Biotechnology
Angiocrine Bioscience, Inc.'s founding year is 2012
